Giandomenico Roviello Selected Research

Giandomenico Roviello Research Topics

Disease

72	Neoplasms (Cancer) 05/2024 - 05/2015
52	Prostatic Neoplasms (Prostate Cancer) 04/2024 - 01/2011
31	Renal Cell Carcinoma (Grawitz Tumor) 01/2024 - 12/2017
24	Stomach Neoplasms (Stomach Cancer) 09/2023 - 01/2016
19	Carcinoma (Carcinomatosis) 04/2024 - 01/2016
14	Disease Progression 01/2024 - 04/2015
13	Neoplasm Metastasis (Metastasis) 04/2024 - 08/2017
12	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2024 - 01/2015
10	Colorectal Neoplasms (Colorectal Cancer) 12/2023 - 01/2012
10	Pancreatic Neoplasms (Pancreatic Cancer) 12/2023 - 04/2015
8	Adenocarcinoma 04/2021 - 01/2015
8	Breast Neoplasms (Breast Cancer) 03/2019 - 01/2015
6	Lung Neoplasms (Lung Cancer) 12/2022 - 01/2016
6	Melanoma (Melanoma, Malignant) 08/2022 - 01/2017
6	Neutropenia 11/2020 - 04/2015
5	Urinary Bladder Neoplasms (Bladder Cancer) 02/2024 - 09/2015
5	Kidney Neoplasms (Kidney Cancer) 07/2023 - 01/2017
5	Ovarian Neoplasms (Ovarian Cancer) 04/2021 - 09/2015
4	Hypertension (High Blood Pressure) 04/2018 - 05/2016
4	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 09/2017 - 11/2015
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2023 - 01/2015
3	COVID-19 11/2023 - 01/2022
3	Hepatocellular Carcinoma (Hepatoma) 11/2021 - 11/2014
3	Thrombocytopenia (Thrombopenia) 08/2021 - 04/2015
3	Fatigue 01/2018 - 10/2015
3	Triple Negative Breast Neoplasms 11/2017 - 06/2016
2	Microsatellite Instability 12/2023 - 03/2023
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 05/2023 - 01/2022
2	Adenocarcinoma of Lung 03/2023 - 01/2022
2	Peripheral Nervous System Diseases (PNS Diseases) 01/2022 - 04/2021
2	Infections 01/2022 - 07/2018
2	Lymphoma (Lymphomas) 01/2022 - 01/2015
2	Sarcoma (Soft Tissue Sarcoma) 01/2022 - 01/2021

Drug/Important Bio-Agent (IBA)

22	Immune Checkpoint InhibitorsIBA 04/2024 - 11/2017
14	Abiraterone AcetateIBA 02/2020 - 04/2014
13	Biomarkers (Surrogate Marker)IBA 12/2023 - 09/2013
13	Bevacizumab (Avastin)FDA Link 07/2021 - 01/2011
12	Tyrosine Kinase InhibitorsIBA 01/2024 - 01/2015
12	Gemcitabine FDA Link 12/2023 - 04/2015
10	NivolumabIBA 01/2024 - 12/2017
10	Docetaxel (Taxotere)FDA Link 07/2019 - 01/2011
8	Oxaliplatin (Eloxatin)FDA LinkGeneric 12/2023 - 01/2012
8	130-nm albumin-bound paclitaxelIBA 12/2023 - 01/2020
8	RamucirumabIBA 09/2023 - 01/2016
8	cabozantinibIBA 01/2023 - 12/2017
7	Hormones (Hormone)IBA 04/2024 - 09/2013
7	Proteins (Proteins, Gene)FDA Link 12/2022 - 01/2015
6	pembrolizumabIBA 05/2024 - 07/2019
6	Everolimus FDA Link 01/2024 - 06/2016
6	Prednisone (Sone)FDA LinkGeneric 01/2022 - 05/2015
5	Cisplatin (Platino)FDA LinkGeneric 05/2024 - 04/2015
5	PlatinumIBA 02/2024 - 02/2020
5	Fluorouracil (Carac)FDA LinkGeneric 12/2023 - 05/2015
5	Paclitaxel (Taxol)FDA LinkGeneric 09/2023 - 01/2016
5	Monoclonal AntibodiesIBA 12/2022 - 01/2016
5	cabazitaxel FDA Link 08/2021 - 09/2015
4	AndrogensIBA 04/2024 - 10/2014
4	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 01/2021
4	Drug CombinationsIBA 10/2021 - 06/2016
4	Trastuzumab (Herceptin)FDA Link 01/2021 - 01/2016
4	Androgen Receptors (Androgen Receptor)IBA 01/2021 - 01/2016
4	Phosphotransferases (Kinase)IBA 08/2020 - 01/2015
4	enzalutamideIBA 06/2019 - 10/2014
4	apatinibIBA 01/2019 - 01/2016
4	abirateroneIBA 12/2018 - 04/2014
4	Epirubicin (Ellence)FDA LinkGeneric 10/2017 - 05/2015
3	enfortumab vedotinIBA 05/2024 - 01/2022
3	lenvatinibIBA 01/2024 - 01/2018
3	pazopanib FDA Link 01/2024 - 01/2023
3	B7-H1 AntigenIBA 12/2023 - 01/2022
3	SodiumIBA 12/2023 - 01/2022
3	Leucovorin (Folinic Acid)FDA Link 12/2023 - 09/2015
3	AfatinibIBA 03/2023 - 01/2015
3	AntigensIBA 09/2022 - 01/2018
3	Capecitabine (Xeloda)FDA Link 01/2022 - 04/2015
3	Vinorelbine (Navelbine)FDA LinkGeneric 05/2020 - 04/2015
3	Radium-223IBA 02/2020 - 10/2015
3	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2018 - 01/2016
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2018 - 01/2016
2	Sunitinib (Sutent)FDA Link 01/2024 - 01/2023
2	Hemoglobins (Hemoglobin)IBA 01/2024 - 01/2023
2	Irinotecan (Camptosar)FDA LinkGeneric 12/2023 - 01/2019
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 12/2023 - 11/2022
2	afliberceptIBA 12/2023 - 07/2021
2	Proton Pump InhibitorsIBA 11/2023 - 01/2023
2	LigandsIBA 01/2023 - 12/2022
2	CTLA-4 AntigenIBA 12/2022 - 11/2017
2	VaccinesIBA 09/2022 - 01/2022
2	Sorafenib (BAY 43-9006)FDA Link 01/2022 - 11/2014
2	AntibodiesIBA 01/2022 - 10/2021
2	taxaneIBA 01/2022 - 09/2015
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 09/2015

Therapy/Procedure

77	Therapeutics 04/2024 - 08/2014
43	Drug Therapy (Chemotherapy) 05/2024 - 01/2012
32	Castration 04/2024 - 10/2014
28	Immunotherapy 01/2024 - 10/2015
6	Radiotherapy 01/2022 - 06/2016
4	Nephrectomy 04/2023 - 01/2021
4	Hyperthermic Intraperitoneal Chemotherapy 01/2022 - 09/2015
3	Neoadjuvant Therapy 04/2023 - 06/2016